Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00117663 · ClinicalTrials.gov registry record · NA
Radiologic Evaluation and Breast Density (READ)
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 1,704
- Enrollment target
NCT00117663: Completed NA study, sponsored by Kaiser Permanente.
NCT00117663 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 1,704 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (21% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00117663, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,704 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether cessation of hormone replacement therapy for one or two months before a screening mammogram will improve its performance by decreasing breast density.
Primary Outcome
Mammography recall was defined as any assessment requiring additional imaging or evaluation of either breast (BI-RADS assessment of 0 for either or both breasts)(30) determined exclusively from the study radiologists' interpretation.
Interventions
- OTHER temporary discontinuation of hormone therapy for 1 month
- OTHER temporary discontinuation of hormone therapy for 2 months
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,704 participants |
| Start Date | 2004-11 |
| Est. Completion | 2007-11 |
| Phase | NA |
What the finished NCT00117663 record still lists
NCT00117663 is an interventional study that assigns participants to a tested intervention. Its 1,704 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (21% higher).
The record links to 0 conditions, and to 2 interventions - of which temporary discontinuation of hormone therapy for 1 month is the first listed.
NCT00117663 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00117663 about?
NCT00117663 is a clinical study titled "Radiologic Evaluation and Breast Density (READ)". The purpose of this study is to determine whether cessation of hormone replacement therapy for one or two months before a screening mammogram will improve its performance by decreasing breast density.
What is the current status of trial NCT00117663?
This trial is currently completed. It is a NA study. The enrollment target is 1,704 participants. The study started on 2004-11. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00117663?
The interventions under investigation include: temporary discontinuation of hormone therapy for 1 month (OTHER), temporary discontinuation of hormone therapy for 2 months (OTHER).
Who is sponsoring clinical trial NCT00117663?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00117663's enrollment target sits among peer trials
1,704 62nd of 2000 higher than 1,939 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07304531 · 1,705 participants
First To Know Pregnancy Test - Clinical Evaluation Protocol
- NCT04321200 · 1,700 participants
PANDA Gym: Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability
- NCT06238622 · 1,700 participants · Phase 3
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
- NCT07284901 · 1,700 participants · Phase 3
Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia